129 related articles for article (PubMed ID: 9875325)
1. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
Bell A; Skinner J; Kirby H; Rickinson A
Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
[TBL] [Abstract][Full Text] [Related]
2. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
Guo B; Stein JL; van Wijnen AJ; Stein GS
Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
[TBL] [Abstract][Full Text] [Related]
3. The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors.
Kirby H; Rickinson A; Bell A
J Gen Virol; 2000 Apr; 81(Pt 4):1057-66. PubMed ID: 10725433
[TBL] [Abstract][Full Text] [Related]
4. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
5. Late induction of CREB/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor.
Feuerstein N; Firestein R; Aiyar N; He X; Murasko D; Cristofalo V
J Immunol; 1996 Jun; 156(12):4582-93. PubMed ID: 8648100
[TBL] [Abstract][Full Text] [Related]
6. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 promoter activity in Epstein-Barr virus-transformed B lymphocytes is controlled by nuclear factor-chi B.
Mouzaki A; Serfling E; Zubler RH
Eur J Immunol; 1995 Aug; 25(8):2177-82. PubMed ID: 7664781
[TBL] [Abstract][Full Text] [Related]
9. Functional importance of the cyclic AMP response element-like decamer motif in the CD8 alpha promoter.
Gao MH; Kavathas PB
J Immunol; 1993 May; 150(10):4376-85. PubMed ID: 8387094
[TBL] [Abstract][Full Text] [Related]
10. The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene.
Xu J; De Zhu J; Ni M; Wan F; Gu JR
Cell Res; 2002 Sep; 12(3-4):177-97. PubMed ID: 12296377
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
Tierney R; Nagra J; Hutchings I; Shannon-Lowe C; Altmann M; Hammerschmidt W; Rickinson A; Bell A
J Virol; 2007 Sep; 81(18):10092-100. PubMed ID: 17626071
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5.
Tierney R; Kirby H; Nagra J; Rickinson A; Bell A
J Virol; 2000 Nov; 74(22):10458-67. PubMed ID: 11044090
[TBL] [Abstract][Full Text] [Related]
13. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.
Tierney RJ; Kirby HE; Nagra JK; Desmond J; Bell AI; Rickinson AB
J Virol; 2000 Nov; 74(22):10468-79. PubMed ID: 11044091
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
Yoo LI; Woloszynek J; Templeton S; Speck SH
J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
[TBL] [Abstract][Full Text] [Related]
16. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines.
Gray JG; Chandra G; Clay WC; Stinnett SW; Haneline SA; Lorenz JJ; Patel IR; Wisely GB; Furdon PJ; Taylor JD
Mol Cell Biol; 1993 Nov; 13(11):6678-89. PubMed ID: 8413264
[TBL] [Abstract][Full Text] [Related]
17. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site.
Jansson A; Johansson P; Li S; Rymo L
J Gen Virol; 2007 Jul; 88(Pt 7):1887-1894. PubMed ID: 17554019
[TBL] [Abstract][Full Text] [Related]
18. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.
Nandi AK; Rapoport AP
Leuk Res; 2006 Apr; 30(4):437-47. PubMed ID: 16171862
[TBL] [Abstract][Full Text] [Related]
19. A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene.
Okabe T; Watanabe T; Kudo A
Eur J Immunol; 1992 Jan; 22(1):37-43. PubMed ID: 1730258
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter.
Zhou Q; Engel DA
J Virol; 1995 Dec; 69(12):7402-9. PubMed ID: 7494244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
